The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
SOST/sclerostin, an osteocyte-derived negative regulator of bone formation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Spemann Organizer Signal noggin Binds and Inactivates Bone Morphogenetic Protein 4
Zimmerman, L. B., De Jesús-Escobar, J. M., & Harland, R. M. (1996) · Cell · doi:10.1016/s0092-8674(00)80133-6 · Cited by 1,633
High Bone Density Due to a Mutation in LDL-Receptor–Related Protein 5
Boyden, L. M., Mao, J., Belsky, J., Mitzner, L., Farhi, A., Mitnick, M. A., Wu, D., Insogna, K., & Lifton, R. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013444 · Cited by 1,591
Minireview: The OPG/RANKL/RANK System
Khosla, S. (2001) · Endocrinology · doi:10.1210/endo.142.12.8536 · Cited by 1,515
Little, R. D., Folz, C., Manning, S. P., Swain, P. M., Zhao, S.-C., Eustace, B., Lappe, M. M., Spitzer, L., Zweier, S., Braunschweiger, K., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/338450 · Cited by 1,282
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
Balemans, W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.5.537 · Cited by 1,147 · cited 5×
“expression by RT-PCR was found in several other organs, including cartilage, bone marrow, kidney, heart, aorta, lung, pancreas, skeletal muscle, liver, skin, and placenta [18,19].”
BackgroundInfluentialPiccolo, S., Sasai, Y., Lu, B., & De Robertis, E. M. (1996) · Cell · doi:10.1016/s0092-8674(00)80132-4 · Cited by 1,126
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
Winkler, D. G. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg599 · Cited by 1,112
Brunkow, M. E., Gardner, J. C., Van Ness, J., Paeper, B. W., Kovacevich, B. R., Proll, S., Skonier, J. E., Zhao, L., Sabo, P. J., Fu, Y.-H., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318811 · Cited by 1,011 · cited 4×
“In 2001, two groups independently identified mutations in a novel gene they called SOST as the cause of sclerosteosis [18,19].”
BackgroundInfluentialvan Bezooijen, R. L., Roelen, B. A. J., Visser, A., van der Wee-Pals, L., de Wilt, E., Karperien, M., Hamersma, H., Papapoulos, S. E., ten Dijke, P., & Löwik, C. W. G. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031454 · Cited by 892
Self-citationBone Morphogenetic Proteins, Their Antagonists, and the Skeleton
Canalis, E., Economides, A. N., & Gazzerro, E. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0023 · Cited by 863
The head inducer Cerberus is a multifunctional antagonist of Nodal, BMP and Wnt signals
Piccolo, S., Agius, E., Leyns, L., Bhattacharyya, S., Grunz, H., Bouwmeester, T., & Robertis, E. M. D. (1999) · Nature · doi:10.1038/17820 · Cited by 832
Bekker, P. J., Holloway, D. L., Rasmussen, A. S., Murphy, R., Martin, S. W., Leese, P. T., Holmes, G. B., Dunstan, C. R., & DePaoli, A. M. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040305 · Cited by 771
BMP-2 Controls Alkaline Phosphatase Expression and Osteoblast Mineralization by a Wnt Autocrine Loop
Rawadi, G., Vayssière, B., Dunn, F., Baron, R., & Roman-Roman, S. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.10.1842 · Cited by 764
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease
Balemans, W., Patel, N., Ebeling, M., Van Hul, E., Wuyts, W., Lacza, C., Dioszegi, M., Dikkers, F. G., Hildering, P., Willems, P. J., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.2.91 · Cited by 698
Hsu, D. R., Economides, A. N., Wang, X., Eimon, P. M., & Harland, R. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80067-2 · Cited by 655
Extracellular Regulation of BMP Signaling in Vertebrates: A Cocktail of Modulators
Balemans, W., & Van Hul, W. (2002) · Developmental Biology · doi:10.1006/dbio.2002.0779 · Cited by 621
Takahashi, N., Udagawa, N., & Suda, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0252 · Cited by 463
Wise, a context-dependent activator and inhibitor of Wnt signalling
Itasaki, N., Jones, C. M., Mercurio, S., Rowe, A., Domingos, P. M., Smith, J. C., & Krumlauf, R. (2003) · Development · doi:10.1242/dev.00674 · Cited by 321
Staehling‐Hampton, K., Proll, S., Paeper, B. W., Zhao, L., Charmley, P., Brown, A., Gardner, J. C., Galas, D., Schatzman, R. C., Beighton, P., et al. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10401 · Cited by 294
Self-citation(1931) · Springer eBooks · doi:10.1007/978-3-642-90787-6 · Cited by 288
Kusu, N., Laurikkala, J., Imanishi, M., Usui, H., Konishi, M., Miyake, A., Thesleff, I., & Itoh, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301716200 · Cited by 274
A Mouse Cerberus/Dan-Related Gene Family
Pearce, J. J. H., Penny, G., & Rossant, J. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9240 · Cited by 273
Laurikkala, J., Kassai, Y., Pakkasjärvi, L., Thesleff, I., & Itoh, N. (2003) · Developmental Biology · doi:10.1016/j.ydbio.2003.08.011 · Cited by 270
Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation
Sutherland, M. K., Geoghegan, J. C., Yu, C., Turcott, E., Skonier, J. E., Winkler, D. G., & Latham, J. A. (2004) · Bone · doi:10.1016/j.bone.2004.05.023 · Cited by 238
The natural history of sclerosteosis
Hamersma, H., Gardner, J., & Beighton, P. (2003) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.00036.x · Cited by 231
Avsian-Kretchmer, O., & Hsueh, A. J. W. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0227 · Cited by 229
Winkler, D. G., Sutherland, M. S. K., Ojala, E., Turcott, E., Geoghegan, J. C., Shpektor, D., Skonier, J. E., Yu, C., & Latham, J. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m400524200 · Cited by 164
Cell fate specification and competence by Coco, a maternal BMP, TGFβand Wnt inhibitor
Bell, E. J. D. H., Muñoz-Sanjuán, I., Altmann, C. R., Vonica, A., & Brivanlou, A. H. (2003) · Development · doi:10.1242/dev.00344 · Cited by 151
van Buchem, F. S. P., Hadders, H. N., & Ubbens, R. (1955) · Acta Radiologica · doi:10.3109/00016925509170789 · Cited by 148
USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney
Yanagita, M., Oka, M., Watabe, T., Iguchi, H., Niida, A., Takahashi, S., Akiyama, T., Miyazono, K., Yanagisawa, M., & Sakurai, T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.075 · Cited by 144
Balemans, W., van den Ende, J., Paes-Alves, A. F., Dikkers, F. G., Willems, P. J., Vanhoenacker, F. M. H. M., de Melo, N. A., Alves, C. F., Stratakis, C. A., Hill, S. C., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302416 · Cited by 135
Reddi, H. (2001) · Arthritis Research · doi:10.1186/ar133 · Cited by 135
The syndromic status of sclerosteosis and van Buchem disease
Beighton, P., Barnard, A., Hamersma, H. A., & van der Wouden, A. (1984) · Clinical Genetics · doi:10.1111/j.1399-0004.1984.tb00481.x · Cited by 133
Uitterlinden, A. G., Arp, P., Paeper, B. W., Charmley, P., Proll, S. C., Rivadeneira, F., Fang, Y., van Meurs, J. B. J., Britschgi, T. B., Latham, J. A., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/426458 · Cited by 133
Noggin and Sclerostin Bone Morphogenetic Protein Antagonists Form a Mutually Inhibitory Complex
Winkler, D. G., Yu, C., Geoghegan, J. C., Ojala, E. W., Skonier, J. E., Shpektor, D., Sutherland, M. K., & Latham, J. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400521200 · Cited by 105
Wergedal, J. E., Veskovic, K., Hellan, M., Nyght, C., Balemans, W., Libanati, C. R., Vanhoenacker, F. M. H. M., Tan, J., Baylink, D. J., & Hul, W. V. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030201 · Cited by 98
Stein, S. A., Witkop, C. J., Hill, S. C., Fallon, M. D., Viernstein, L. J., Gucer, G., McKeever, P. E., Long, D. M., Altman, J., Miller, N. R., et al. (1983) · Neurology · doi:10.1212/wnl.33.3.267 · Cited by 97
Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblasts
Sutherland, M. K., Geoghegan, J. C., Yu, C., Winkler, D. G., & Latham, J. A. (2004) · Bone · doi:10.1016/j.bone.2004.04.019 · Cited by 93
Iwasaki, S., Tsuruoka, N., Hattori, A., Sato, M., Tsujimoto, M., & Kohno, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5476 · Cited by 89
Beighton, P. (1988) · Journal of Medical Genetics · doi:10.1136/jmg.25.3.200 · Cited by 85
van der Horst, G., van Bezooijen, R. L., Deckers, M., Hoogendam, J., Visser, A., L�wik, C. W. G. M., & Karperien, M. (2002) · Bone · doi:10.1016/s8756-3282(02)00903-1 · Cited by 79
Self-citationCbfa1/RUNX2 Directs Specific Expression of the Sclerosteosis Gene (SOST)
Sevetson, B., Taylor, S., & Pan, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306249200 · Cited by 77
Sclerosteosis — An autosomal recessive disorder
Beighton, P., Davidson, J. S., Durr, L., & Hamersma, H. A. (1977) · Clinical Genetics · doi:10.1111/j.1399-0004.1977.tb01269.x · Cited by 77
Osteopetrosis with syndactyly; a morphological variant of Albers-Schönberg's disease.
As, T. (1958) · PubMed · Cited by 71
Ohyama, Y., Nifuji, A., MAEDA, Y. Y., Amagasa, T., & Noda, M. (2004) · Endocrinology · doi:10.1210/en.2003-1492 · Cited by 69
Truswell, A. S. (1958) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.40b2.208 · Cited by 65
Balemans, W., Foernzler, D., Parsons, C. A., Ebeling, M., Thompson, A., Reid, D. M., Lindpaintner, K., Ralston, S. H., & Hul, W. V. (2002) · Bone · doi:10.1016/s8756-3282(02)00844-x · Cited by 47
Van Buchem disease: lifetime evolution of radioclinical features
Vanhoenacker, F. M. H. M., Balemans, W., Tan, G. J., Dikkers, F. G., de Schepper, A. M., Mathysen, D. G. P., Bernaerts, A., & Hul, W. V. (2003) · Skeletal Radiology · doi:10.1007/s00256-003-0675-4 · Cited by 39
Endocrine function in sclerosteosis.
Epstein, S., Hamersma, H. A., & Beighton, P. (1979) · PubMed · Cited by 32
Van Buchem's Disease (Hyperostosis Corticalis Generalisata Familiaris): A Case Report
Fosmoe, R. J., Holm, R. S., & Hildreth, R. C. (1968) · Radiology · doi:10.1148/90.4.771 · Cited by 24
Bone Morphogenetic Proteins and their Receptors
van Bezooijen, R. L., Heldin, C., & ten Dijke, P. (2006) · Encyclopedia of Life Sciences · doi:10.1038/npg.els.0004197 · Cited by 12
Self-citation
Cited by
BIOMECHANICAL AND MOLECULAR REGULATION OF BONE REMODELING
Robling, A. G., Castillo, A. B., & Turner, C. H. (2006) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095721 · Cited by 1,343
Mechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/Sclerostin
Robling, A. G., Niziolek, P. J., Baldridge, L. A., Condon, K. W., Allen, M. R., Alam, I., Mantila, S. M., Gluhak-Heinrich, J., Bellido, T. M., Harris, S. E., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705092200 · Cited by 1,350
Osteocytes, mechanosensing and Wnt signaling
Bonewald, L. F., & Johnson, M. L. (2008) · Bone · doi:10.1016/j.bone.2007.12.224 · Cited by 1,076
Bone remodeling during fracture repair: The cellular picture
Schindeler, A., McDonald, M. M., Bokko, P., & Little, D. G. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.07.004 · Cited by 961
Inflammatory bone loss: pathogenesis and therapeutic intervention
Redlich, K., & Smolen, J. S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3669 · Cited by 830
Metadata
- Authors
- Bezooijen, R. L. V., Dijke, P. T., Papapoulos, S. E., & G.M. Löwik, C. W.
- Venue
- Cytokine & Growth Factor Reviews
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 16
- Issue
- 3
- Pages
- 319-327
- ISSN
- 1359-6101 (ISSN-L)
- OpenAlex
- W2091514824
- Cited by
- 367
- References
- 51
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.